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The mechanistic target of rapamycin complex 1
(mTORC1) senses diverse signals to regulate cell
growth and metabolism. It has become increasingly
clear that mTORC1 activity is regulated in time
and space inside the cell, but direct interrogation
of such spatiotemporal regulation is challenging.
Here, we describe a genetically encoded mTORC1
activity reporter (TORCAR) that exhibits a change in
FRET in response to phosphorylation by mTORC1.
Co-imaging mTORC1 activity and calcium dynamics
revealed that a growth-factor-induced calcium
transient contributes to mTORC1 activity. Dynamic
activity maps generated with the use of subcellularly
targeted TORCAR uncovered mTORC1 activity not
only in cytosol and at the lysosome but also in the nu-
cleus and at the plasma membrane. Furthermore, a
wide distribution of activities was observed upon
growth factor stimulation, whereas leucine ester, an
amino acid surrogate, induces more compartmental-
ized activities at the lysosome and in the nucleus.
Thus, mTORC1 activities are spatiotemporally regu-
lated in a signal-specific manner.
INTRODUCTION
The mechanistic target of rapamycin (mTOR) is a highly
conserved serine/threonine protein kinase. mTOR is the key cat-
alytic component of two structurally and functionally distinct
complexes named mTORC1 (mTOR complex 1) and mTORC2
(mTOR complex 2). The rapamycin-sensitive mTORC1 is
composed of three essential components: the kinase mTOR,
the signature subunit Raptor (regulatory associated protein of
mTOR), and the mLST8 subunit (mammalian lethal with sec13
protein 8) that is also present in the rapamycin-insensitive
mTORC2. As a critical signaling hub, mTORC1 senses diverse
signals, such as growth factors (GFs), amino acids (AAs), stress,
oxygen, and changes in energy levels.When activated, mTORC1
promotes protein and lipid synthesis and inhibits autophagy toCellcontrol cell growth and cell metabolism. Because of its pivotal
role in a large number of cellular processes, aberrant regulation
of mTORC1 has been shown to be associated with human can-
cers, cardiovascular disease, and metabolic disorders such as
type 2 diabetes (Dibble and Manning, 2013).
The activation of mTORC1 is exquisitely regulated in response
to distinct upstream cues. GF activates mTORC1 via the PI3K/
Akt pathway and the Erk/RSK pathway at the level of the Tuber-
ous Sclerosis Complex 2 (TSC2) (Dibble and Manning, 2013).
Within the TSC complex (TSC1/TSC2/TBC1D7), TSC2 functions
as a gatekeeper for mTOR activity by acting as a GTPase-acti-
vating protein (GAP) toward Rheb GTPase, thus promoting
GTP hydrolysis and inhibiting Rheb. GTP-bound Rheb is an
essential and direct upstream activator of mTORC1 (Dibble
and Manning, 2013). Akt and Erk, as well as RSK downstream
of Erk, phosphorylate the TSC2 and thereby allow Rheb to acti-
vate mTORC1. Unlike GFs, AAs communicate to mTORC1
through the Rag GTPase complex and the Ragulator complex
that anchors the Rags to the lysosome (Bar-Peled et al., 2012;
Kim et al., 2008; Sancak et al., 2008, 2010). In response to
AAs, the Rag GTPase complex is activated and subsequently re-
cruits mTORC1 to the lysosome, where the Rheb GTPase is also
present. Therefore, the close proximity of mTORC1 and Rheb at
the lysosome allows the immediate activation of the complex,
assuming Rheb is loaded with GTP and active. When AAs are
absent, the Rag GAP complex (GATOR1) inactivates the Rag
GTPases and leads to the dissociation ofmTORC1 from the lyso-
somal surface (Bar-Peled et al., 2013).
Given that both GF and AA signals specifically impinge on
mTORC1, an intriguing question is how this signaling specificity
is achieved inside the cell. Spatial compartmentalization may be
a key mechanism. Indeed, mTOR has been shown to be local-
ized to several distinct subcellular compartments, including the
lysosome, mitochondria, plasma membrane, endoplasmic retic-
ulum, and nucleus, although in some cases the evidence is
disputable (Betz and Hall, 2013). At the lysosome, the best char-
acterized site of mTORC1 activation, Menon et al. (2014) have
recently shown that GF signaling pathways directly activate
mTORC1, independent of AA signaling, by promoting the
release of the inhibitory TSC complex from lysosomes. It has
also been reported in a parallel study that Rag GTPase recruits
TSC2 to the lysosomal surface upon AA removal to inactivateReports 10, 1767–1777, March 17, 2015 ª2015 The Authors 1767
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Figure 1. Domain Structures of TORCAR Candidate Constructs
(A) Domain structures of candidate constructs based on a generalizedmodular
design. The top construct used a fragment of Ulk1 as the substrate motif
and the WW domain as the PAABD, and the bottom constructs used the
consensus substrate motifs from peptide positioning screening studies.
(B) Domain structures of candidate constructs based on putative conforma-
tional change in full-lengthor fragmentsof 4EBP1uponphosphorylation. -, <5%
response; +, 5%–10% response; ++, 10%–15% response; +++, >15%
response. See also Figure S1.mTORC1 (Demetriades et al., 2014). Therefore, both the activa-
tion and inactivation of mTORC1may be intricately regulated in a
signal- and location-specific manner. However, aside from the
lysosome, the activity of mTORC1 at various other cellular loca-
tions has not been well characterized.
To shed light on compartmentalized mTORC1 signaling, we
generated and characterized a genetically encoded mTORC1
activity reporter (TORCAR) to enable the characterization of
mTORC1 signaling dynamics in single living cells. By co-imaging
TORCAR along with a calcium probe, we uncovered that a tran-
sient intracellular calcium increase induced by platelet-derived
growth factor (PDGF) contributes to mTORC1 activity. To reveal
the spatial regulation of mTORC1, TORCARwas then targeted to
distinct subcellular locations, including lysosome, the plasma1768 Cell Reports 10, 1767–1777, March 17, 2015 ª2015 The Authormembrane, and the nucleus. Surprisingly, we detected GF-
stimulated mTORC1 activity at all the examined locations,
including the nuclear site in dispute, whereas leucine ester-
induced mTORC1 activity only occurs at the lysosome and in
the nucleus, indicating that AA sensing and signaling to mTOR
are rather local.
RESULTS
Development of mTORC1 Activity Reporters
To monitor mTORC1 activity in living cells, we designed a series
of biosensor candidate constructs based on different strategies
for generating a FRET (fluorescence resonance energy transfer)-
based kinase activity biosensor (Ni et al., 2006; Zhou et al.,
2012). In general, such biosensors consist of a kinase activity-
dependent molecular switch sandwiched between a FRET-
capable fluorescent protein (FP) pair. Our first strategy utilized
an engineered molecular switch flanked with a cyan FP (CFP)/
yellow FP (YFP) FRET pair. An engineered molecular switch is
constructed by coupling a sensing domain, which usually is a
peptide substrate that can be recognized and phosphorylated
by a kinase of interest, to a domain that specifically binds
to phosphoamino acids (phosphoamino acid-binding domain
[PAABD]). When phosphorylated, the substrate falls into the
binding pocket of the PAABD, and this engineered conforma-
tional change in the molecular switch can be read out as a
change in FRET. Thus, by analogy to the previously engineered
PKA activity reporter (AKAR) (Zhang et al., 2001), PKC activity re-
porter (CKAR) (Violin et al., 2003), and AMPK activity reporter
(AMPKAR) (Tsou et al., 2011), we designed several candidate
constructs based on the mTORC1 substrate consensus motifs
identified by a study using positional peptide screening (Hsu
et al., 2011). The designed mTORC1 substrate sequences
were further modified to accommodate the binding preference
of FHA1, a phosphothreonine binding domain, to prompt a phos-
phorylation-dependent conformational change (Figure 1A). Simi-
larly, a candidate biosensor using a fragment of Ulk1 containing
the mTORC1-specific phosphorylation site Ser757 (Kim et al.,
2011) and the phosphoserine/phosphothreonine binding WW
domain was also constructed (Figure 1A). However, when tested
in living cells, these candidate biosensors did not show any re-
sponses when mTORC1 activity was stimulated.
As an alternative strategy, any naturally existing conformation-
ally responsive element can be used as the switch when con-
structing a biosensor (Calleja et al., 2007). To test this strategy,
we designed biosensors using full-length or truncated fragments
of 4EBP1 (eIF4Ebinding protein 1) sandwichedbetweenCFPand
YFP (Figures 1B and S1A). The phosphorylation of 4EBP1 is
thought to induce a conformational change that leads to its
release from eIF4E, thereby relieving its repression of translation
(Fletcher and Wagner, 1998; Gosselin et al., 2011). In addition,
another well-characterized mTORC1 substrate (Burnett et al.,
1998), p70 S6K, was tested in a similar format (Figure S1B).
Among these constructs, the one containing full-length 4EBP1
sandwiched between Cerulean and Venus was shown to be
responsive (Figure1B).Serum-andAA-starved (hereafter referred
to as double starved [DS] and the starvation condition used if
not otherwise indicated) NIH 3T3 fibroblasts expressing thiss
A B
C D
E F
G H
Figure 2. Characterization of TORCAR
(A) Domain structure of TORCAR and TORCAR (T37/46A).
(B) Image of an NIH 3T3 cell expressing TORCAR. Scale bar represents
10 mm.
(C) Representative time course of the TORCAR response to PDGF. Double
Starved (Serum- and Amino acid-starved, referred to as DS) NIH 3T3 cells
expressing TORCAR (blue trace, mean response ± SEM as 13.3% ± 6.0%,
Cellconstruct showed a consistent increase in the cyan-over-yellow
(C/Y) emission ratio in response to PDGF stimulation, reflecting
a decrease in energy transfer efficiency due to the putative phos-
phorylation-induced conformational change in 4EBP1. To im-
prove the dynamic range of the biosensor, we tested various
combinations of FPs as FRET pairs (Figure 1B). The biosensor
with Cerulean/YPet as the FRET pair showed the largest increase
in emission ratio (C/Y) in response to PDGF stimulation.
Characterization of TORCAR
NIH 3T3 cells expressing the biosensor containing full-length
4EBP1 flanked by Cerulean and YPet (Figure 2A) exhibited uni-
form cyan and yellow fluorescence throughout the cell, suggest-
ing that the reporter is distributed evenly in both the cytosol and
nucleus (Figure 2B). PDGF addition induced a 13.3% ± 6.0% in-
crease in emission ratio (C/Y) with a t1/2 of 12.2 ± 3.2 min (Fig-
ure 2C, blue trace, n = 33). To examine whether the increase in
the ratio (C/Y) is indicative of an increase in mTOR kinase activity,
we added torin1, a potent mTOR inhibitor, following PDGF
stimulation. Torin1 addition immediately reversed the reporter
response (Figure 2D, n = 8). In addition, pretreating NIH 3T3 cells
with torin1 abolished the response to PDGF (Figure 2E, n = 6),
suggesting that the reporter response reflects the mTOR kinase
activity. Addition of torin1 to nonstarved 3T3 cells expressing
this reporter also led to a rapid decrease in emission ratio, indi-
cating the presence of basal activity (n = 6, Figure S2A).We further
examinedwhether the TORCAR response is specific tomTORC1.
In these experiments, the addition of rapamycin, a selective
inhibitor for mTORC1, following PDGF stimulation, reversed the
PDGF-induced response (Figure S2B, n = 8). Pretreatment with
rapamycinalsoblockedthePDGF-inducedresponse (FigureS2C,
n = 4). Taken together, these results indicate that this biosensor
specifically detects mTORC1 activity in cells; therefore, we
named it TORCAR (mTORC1 Activity Reporter).
We then asked whether the FRET ratio change is dependent
on the phosphorylation of the reporter by mTORC1. 4EBP1 is
known to be phosphorylated at multiple sites, including T37,
T46, S65, T70, S83, and S112 (Fadden et al., 1997; Heesom
et al., 1998). Phosphorylation at T37 and T46 was shown to be
mTORC1 specific (Gingras et al., 1999; Thoreen et al., 2009). A
mutant TORCAR containing T37A and T46A in the 4EBP regionmean t1/2 ± SEM as 12.2 ± 3.3 min, n = 33) or TORCAR-T37/46A (red trace, n =
10) were stimulated with 50-ng/ml PDGF.
(D) PDGF-induced TORCAR response was reversed upon addition of torin1
(1 mM) (n = 8).
(E) Pretreatment with torin1 (200 nM) abolished the PDGF-induced TORCAR
response (n = 6).
(F) Immunoblots showing the time course for the phosphorylation levels of
TORCAR, endogenous 4EBP1 (p-T37/46), and p70 S6K1 (p-T389) (n = 3). DS
NIH 3T3 cells expressing TORCAR were stimulated with PDGF (50 ng/ml) for
the indicated times.
(G) Representative time course of the TORCAR FRET response to Leucine
methyl ester. DS NIH 3T3 cells expressing TORCAR (blue trace, n = 6) or
TORCAR-T37/46A (red trace, n = 5) were stimulated with 7.5 mM LeuOMe.
(H) Immunoblots showed the time course for the phosphorylation levels of
TORCAR, endogenous 4EBP1 (p-T37/46), and p70 S6K1 (p-T389) (n = 3). DS
NIH 3T3 cells expressing TORCAR were stimulated with LeuOMe (7.5 mM) for
the indicated times. See also Figure S2.
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failed to respond to PDGF and torin1 addition (Figure 2C, red
trace, n = 10). Consistent with these data, the time course for
PDGF-induced phosphorylation at T37/46 of 4EBP1 in TORCAR,
as well as endogenous 4EBP1 (T37/46) and p70 S6K1 (T389),
correlated with the emission ratio change (Figure 2F). We next
examined whether TORCAR is able to detect mTORC1 activity
in other cell types. Similar to the response in NIH 3T3 cells, insulin
induced an increase in the C/Y emission ratio in DS HeLa cells
(Figure S2D, n = 4) and 3T3-L1 adipocytes (Figure S2E, n = 10)
expressing TORCAR, suggesting that TORCAR also provides a
selective FRET readout for mTORC1 in these cell types.
AAs, especially leucine, have been shown to activatemTORC1
(Dodd and Tee, 2012; Jewell and Guan, 2013). Indeed, TORCAR
responded to a complete AA mixture with an emission ratio
change of 11.2% ± 3.0% (n = 4, Figure S2F) and 4.2% ± 2.2%
(n = 10, Figure S2G) in DS 3T3 cells and AA-starved 3T3 cells,
respectively. Compared with a total AA mixture, leucine ap-
peared to be a weaker stimulus of mTORC1 activity, indicated
by both the TORCAR response (Figures S2H and S2I) and the
phosphorylation of mTORC1 substrates (Figure S2J). To further
characterize TORCAR, we treated NIH 3T3 cells with leucine
O-methyl ester (LeuOMe), which bypasses AA transporters
and diffuses freely across membranes, after which it is hydro-
lyzed to native leucine (Reeves, 1979; Zoncu et al., 2011). The
addition of leucine ester also induced an increase in the C/Y
emission ratio (Figure 2G, blue trace, n = 6) that was dependent
on the presence of T37 and T46 (Figure 2G, red trace, n = 5).
Parallel WB analysis confirmed that leucine ester induces the
phosphorylation of T37/46 in both TORCAR and endogenous
4EBP1 (T37/46) and p70 S6K1 (T389) (Figure 2H). Furthermore,
stimulation with PDGF and AAs showed additive effects on the
TORCAR response (Figures S2K and S2L) and phosphorylation
(Figure S2M). Consistent with previous studies (Roux et al.,
2004; Tee et al., 2003), the phorbol ester PMA also induced a
specific response (Figures S2N and S2O), presumably via the
ERK/RSK pathway.
PDGF-Induced Calcium Transient Contributes to
mTORC1 Activity
Previous studies indicated that the intracellular calcium plays a
role in mTORC1 activation. For example, the leucine-induced
activation of S6K1 has been shown to require the mobilization
of intracellular Ca2+ in skeletal myoblasts, which is mediated
by the SHP-2/PLC b4/IP3 pathway (Mercan et al., 2013). It has
also been suggested that AAs or insulin treatment in HeLa cells
induced a rise in intracellular Ca2+, which triggered mTORC1
activation (Gulati et al., 2008). We therefore asked whether cal-
cium contributes to GF-stimulated TORC1 activity. To test the
involvement of calcium, we co-expressed a calcium probe,
RCaMP, with TORCAR in NIH 3T3 cells to simultaneously track
calcium dynamics and mTORC1 activity changes. RCaMP con-
sists of a red FP (RFP, cp-mRuby) flanked by calmodulin (CaM)
and the Ca2+/CaM-binding peptide M13 (Figure 3A) (Akerboom
et al., 2013). When Ca2+ binds to CaM in RCaMP, it induces a
conformational change that leads to an increase in RFP intensity.
Co-imaging TORCAR and RCaMP revealed a transient peak of
intracellular calcium inNIH 3T3 cells upon PDGF stimulation (Fig-
ure 3B, red trace), which occurs right before the onset of the1770 Cell Reports 10, 1767–1777, March 17, 2015 ª2015 The AuthorTORCAR response (Figure 3B, blue trace, 13.2% ± 6.9%, n =
25). Removing the extracellular calcium using EGTA in cal-
cium-free medium did not prevent the PDGF-induced calcium
transient, suggesting that this calcium increase originates from
intracellular store (Figure S3A, n = 4). To examine whether this
PDGF-induced intracellular calcium increase contributes to
mTORC1 activity, we treated cells with a cell-permeant calcium
chelator, BAPTA-AM, before PDGF stimulation. BAPTA-AM
treatment abolished the calcium increase and decreased the
amplitude of the TORCAR response by approximately 40%
(7.7% ± 2.9%, n = 18, p < 0.0001), suggesting that calcium plays
a significant role in mTORC1activity (Figure 3C). Consistent with
this observation, WB analysis confirmed that the PDGF-induced
phosphorylation of TORCAR at 4EBP T37/46 was reduced by
BAPTA-AM (Figure 3D). In addition, BAPTA alone also caused
a slight decrease in the TORCAR emission ratio (Figures 3C
and S3B), as well as a slight reduction in the phosphorylation
of TORCAR (Figures 3D and S3C), suggesting that both basal
calcium and the PDGF-induced calcium spike may contribute
to mTORC1 activity.
We further asked whether BAPTA-AM impairs PDGF-induced
Akt activity. Previously, we developed the Akt activity reporter
(AktAR) to allow the real-time tracking of intracellular Akt activity
(Gao and Zhang, 2008). A new version of AktAR with an
enhanced dynamic range was generated then by replacing the
Cerulean of AktAR with Cerulean3, a brighter variant of CFP
(Markwardt et al., 2011) (Figures S3D–S3F). Imaging with this
improved Akt activity reporter, AktAR2, showed that pretreat-
ment with BAPTA-AM reduced the PDGF-stimulated AktAR2
response (2.8% ± 2.9%, n = 8, Figure S3G) compared with the
response without BAPTA-AM pretreatment (9% ± 6%, n = 10,
p < 0.01, Figure S3H) in these DS cells. Of note, AA starvation
(Figures S3H and S3I) significantly lowered PDGF-induced Akt
activity compared with control cells (Figure S3F), implying that
AAs deprivation suppressed PDGF-stimulated Akt activity (Fig-
ure S3J) (Tato et al., 2011). Furthermore, whereas the PDGF-
induced phosphorylation of Akt T308 was not significantly
altered, the phosphorylation of Akt S473, which is targeted by
mTORC2,was attenuated byBAPTA-AM (Figure 3D). In addition,
BAPTA pretreatment also lowered the phosphorylation of S422
SGK1, another mTORC2 target (Figure 3D), suggesting that
mTORC2 activity is affected. These data suggest that both
mTORC1 and mTORC2 activities are affected by calcium.
Lysosomal Akt Activity during GF-Induced mTORC1
Activation
Lysosomal mTORC1activity has remained an important point of
interest. In response to AAs, the Rag complex recruits mTOR
from a poorly characterized cytoplasmic location to the lyso-
somal surface (Zoncu et al., 2011), suggesting that lysosomes
act as a signaling platform for mTORC1 regulation and function.
To detect mTORC1 activity at the lysosome, we generated a
lysosome-targeted TORCAR (Lyso-TORCAR) by attaching
LAMP1 (lysosome associated membrane protein 1) to the N ter-
minus of TORCAR (Figure 4A). NIH 3T3 cells expressing Lyso-
TORCAR exhibited fluorescence in small punctate structures
that can be co-stained with LysoTracker Red, a red lysosomal
marker (Figure 4B).s
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Figure 3. Calcium Plays a Role in GF-
Induced mTORC1 Activity
(A) Domain structures of TORCAR and RCaMP.
(B) DS NIH 3T3 cells co-expressing TORCAR and
RCaMP responded to PDGF with a calcium tran-
sient and an increase in FRET ratio (C/Y) (mean
response ± SEM as 13.2% ± 6.9%, n = 25).
(C) Pretreatment with BAPTA-AM, an intracellular
calcium chelator, antagonized the calcium peak
and lowered the TORCAR response to PDGF
(mean response ± SEM as 7.7% ± 2.9%, n = 18,
p < 0.0001 by two-tailed t test).
(D) Immunoblots showed the phosphorylation
levels of TORCAR, endogenous 4EBP1 (p-T37/
46), p70 S6K1 (p-T389), phospho-Akt, and total
Akt upon different treatments (n = 3). Control: no
drug added. PDGF: PDGF (50 ng/ml) was added at
time 0, and cells were collected after 30 min.
BAPTA+PDGF: BAPTA-AM (20 mM) was added at
time 0, and PDGF (50 ng/ml) was added after
15 min; cells were collected 30 min after PDGF
addition. BAPTA: BAPTA-AM (20 mM) was added,
and cells were collected after 15 min. See also
Figure S3.We first tested the response of Lyso-TORCAR to leucine
methyl ester, which diffuses freely across membranes and is
hydrolyzed to native leucine within lysosomes. Consistent withCell Reports 10, 1767–1777the notion that leucine activates
mTORC1 at the lysosome, a 4.6% ±
2.5% response was observed in DS
NIH 3T3 cells (Figure 4C, n = 5).
The negative control, Lyso-TORCAR-TA
(T37/46A) (Figure S4A), failed to respond
to leucine ester, suggesting that the
response is phosphorylation dependent
(Figure S4B, n = 4). Lyso-TORCAR also
responded to a total AA mixture and
leucine in DS or AA-starved 3T3 cells
(Figures S4C–S4F).
In contrast to the mechanisms of
activation by AAs, which involves the
Rag complex, GFs activate mTORC1
largely via Akt/TSC/Rheb signaling (Lap-
lante and Sabatini, 2009). Recently, it
has been shown that the TSC com-
plex localizes to the lysosome (Deme-
triades et al., 2014; Dibble et al., 2012;
Menon et al., 2014), where subpopula-
tions of Rheb and mTOR are also
present (Ohsaki et al., 2010; Sancak
et al., 2010). We then asked whether
Lyso-TORCAR could detect GF-induced
mTORC1 activity at this location. As
shown in Figure 4D, PDGF treatment
indeed stimulated a 6.8% ± 2.1%
response in DS NIH 3T3 cells ex-
pressing Lyso-TORCAR (n = 8), indi-
cating PDGF induced mTORC1 activityon the lysosomal outer membrane. The T-to-A mutation,
Lyso-TORCAR-TA (T37/46A), abolished the response (Fig-
ure S4G, n = 3)., March 17, 2015 ª2015 The Authors 1771
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Figure 4. mTORC1 Activity at the Lyso-
somal Membrane
(A) Domain structures of lysosome-targeted
TORCAR (Lyso-TORCAR).
(B) Image ofNIH3T3 cells expressing Lyso-
TORCAR, co-stained with LysoTracker Red. Scale
bar represents 10 mm.
(C) Lyso-TORCAR responded to LeuOMe (mean
response ± SEM as 4.6% ± 2.5%, n = 5).
(D) PDGF addition induced a Lyso-TORCAR
response (mean response ± SEM as 6.8% ± 2.1%,
n = 8).
(E) Pretreating DS NIH 3T3 cells with the Akt in-
hibitor, 10-DEBC (30 mM, 5 min), abolished the
PDGF-induced Lyso-TORCAR response (n = 4).
See also Figure S4.ThisGF-induced lysosomalmTORC1activity could result either
from the translocation of mTORC1 activated elsewhere or from a
subpool of lysosome-residentmTORC1beingactivated locally via
theAkt/TSC1/2/Rhebpathway. To testwhether lysosomal Akt ac-
tivity is contributing to local mTORC1 activity, we monitored Akt
activity on the lysosomal membrane using a lysosomal targeted
AktAR, Lyso-AktAR2 (Figure S4A). Lyso-AktAR2was constructed
by tagging LAMP1 to the N terminus of the improved AktAR,
AktAR2. When expressed, Lyso-AktAR2 exhibited punctate fluo-
rescence in the cytosol that co-localized with LysoTracker Red
(Figure S4H). PDGF stimulated a 6.0% ± 2.6% response from1772 Cell Reports 10, 1767–1777, March 17, 2015 ª2015 The Authorsthe lysosomal Akt reporter (Figure S4I,
n = 4), whereas the T/A negative control
of the lysosomal Akt reporter showed no
response (Figure S4J, n = 3), suggesting
thatPDGF inducedAkt activity on the lyso-
somal surface. Pretreatment with an Akt
specific inhibitor, 10-DEBC at the concen-
tration of 30 mM, inhibited the lysosomal
Akt activity induced by PDGF (Figure S4K,
n = 3). Importantly, the PDGF-induced
Lyso-TORCAR response was largely in-
hibited aswell (Figure 4E, n = 4). Similar re-
sultswerealsoobservedwhenanotherAkt
inhibitor, SH-5,was used (FiguresS4L and
S4M). Collectively, these results implied
that GFs efficiently and acutely induced
mTORC1 activity increases at the lyso-
someand that these increasesare, at least
inpart,mediatedby lysosomalAkt activity.
These data are consistent with the newly
identified role of Akt in phosphorylating
TSC2, leading to the dissociation of the
TSC complex from the lysosome and the
activation of mTORC1 at this location
(Menon et al., 2014).
GF Induced mTORC1 Activity at the
Plasma Membrane
Upon GF stimulation, Akt is recruited to
the plasma membrane through the spe-cific binding of its PH domain to the accumulating PIP3 at the
membrane, and this translocation event has been shown to be
critical for Akt activation. Hence, we asked whether GF specif-
ically stimulatedmTORC1 activity at the plasmamembrane. Pre-
viously, subcellular fractionation of endothelial cells revealed the
presence of mTOR and Raptor in plasmamembrane rafts (Parto-
vian et al., 2008), which are cholesterol-rich, detergent-insoluble
microdomains known to function as pivotal signaling platforms
(Hanzal-Bayer and Hancock, 2007). Whereas TSC2 may be
present at the plasma membrane (Wienecke et al., 1995), the
plasma membrane localization of the proximal activator of
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Figure 5. mTORC1 Activity at the Plasma
Membrane
(A) Domain structures of plasma membrane-tar-
geted TORCAR.
(B) Confocal image of an NIH 3T3 cell expressing
PM-TORCAR. Line scans showed the intensity
of PM-TORCAR across the plasma membrane
(n = 3). Scale bar represents 10 mm.
(C) PM-TORCAR responded to PDGF (mean
response ± SEM as 7.6% ± 3.3%, n = 30).
(D) PM-TORCAR showed no response to leucine
ester (n = 3).
See also Figure S5 and Movie S1.mTORC1, Rheb, is unclear. Rheb has been suggested to localize
throughout the endomembrane system but not at the plasma
membrane due to its lack of either palmitoylation sites or
polybasic-rich sequences for plasma membrane targeting
(Takahashi et al., 2005). On the other hand, an earlier study
reported that Rheb is associated with the plasma membrane
in NIH 3T3 cells and enriched in the apparent membrane ruffle
regions (Clark et al., 1997). We also found Rheb in membrane
raft fractions from either plasma membrane or endomembrane
(Figure S5A). To address whether the mTORC1 activity is pre-
sent at the plasma membrane, we constructed TORCAR tar-
geted to the plasma membrane (PM-TORCAR) by fusing the
Lyn-targeting motif to the N terminus of TORCAR (Gao and
Zhang, 2008) (Figure 5A). When expressed in cells, PM-
TORCAR is properly targeted to the plasma membrane, with
the majority of fluorescence detected at the cell membrane (Fig-
ure 5B). Upon PDGF stimulation, PM-TORCAR showed a robust
response (7.6% ± 3.3%, n = 30) (Figure 5C), whereas the T-to-A
mutant of PM-TORCAR (Figure S5B) showed no response (Fig-
ure S5C, n = 3). Whereas it is still unclear if the TSC/Rheb
pathway mediates the plasma membrane mTORC1 activity, itCell Reports 10, 1767–1777is noteworthy that another player, Ral
GTPase, has been recently suggested
to regulate the serum-induced transloca-
tion of mTORC1 to the plasma mem-
brane (Martin et al., 2014), providing a
possible mechanism underlying plasma
membrane mTORC1 activity. Interest-
ingly, PM-TORCAR showed no response
to leucine methyl ester (Figure 5D, n = 3),
indicating that the mTORC1activity de-
tected at the plasma membrane is GF
specific.
mTORC1 Activity Is Present in the
Nucleus
Many reports have suggested the pres-
ence of mTOR and Raptor (mTORC1),
as well as the downstream effector S6K
in the nucleus (Betz and Hall, 2013). In
addition, the functional relevance of the
nuclear mTORC1 has also been indicated
(Workman et al., 2014). However, it isunclear whether functional endogenous mTORC1 exists in the
nucleus. In fact, mTORC1 is considered to be non-nuclear, and
the major function of mTORC1 signaling is largely considered
to be the result of mTOR kinase activity toward cytoplasmic
substrates (Betz and Hall, 2013; Rosner and Hengstschla¨ger,
2012). To probe the nuclear mTORC1 activity, we constructed
a nuclear-targeted TORCAR (TORCAR-NLS) by tagging a nu-
clear localization sequence (NLS) to the C terminus of TORCAR
(Ananthanarayanan et al., 2005) (Figure 6A). TORCAR-NLS is
localized exclusively in the nucleus when expressed in NIH 3T3
cells, as indicated by co-staining with Nuclear-ID Red (Fig-
ure 6B). PDGF induced a 10% ± 4% response with a t1/2 of
13.3 ± 2.6 min (n = 11), suggesting that there is a pool of
mTORC1 activity in nucleus (Figure 6C). Pretreatment with torin1
abolished the PDGF-induced response, indicating that the
response is mTOR-specific (Figure 6D, n = 4). Curiously, leucine
ester induced a similar response to that of PDGF (Figure 6E,
8.2% ± 1.8%, n = 7). These data suggested that both GF and
AA signaling can induce mTORC1 activity in the nucleus, with
kinetics on par with the cytosolic accumulation of mTORC1
activity., March 17, 2015 ª2015 The Authors 1773
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Figure 6. Nuclear mTORC1 Activity
(A) Domain structures of nuclear-targeted TORCAR (TORCAR-NLS).
(B) Image of anNIH3T3 cell expressing TORCAR-NLS. Scale bar represents
10 mm.
(C) TORCAR-NLS responded to PDGF with a mean response ± SEM as
10.2% ± 4.1% and mean t1/2 ± SEM as 13.3 ± 2.6 min (n = 11).
(D) Pretreating cells with torin1 (1mM, 10 min) abolished the PDGF-induced
TORCAR-NLS response (n = 4).
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Distinct upstream signals impinge on mTORC1, which controls
cell growth and metabolism. A critical question is how this com-
plex senses these different inputs and transduces the specific
signals to precisely control cell growth. The lysosomal activation
of mTORC1 highlighted the signal- and location-specific regula-
tion of mTORC1 and prompted us to examine the spatial regula-
tion of mTORC1 activity. To achieve this goal, we needed a
molecular tool that allowed for sensitive detection of the activity
of the intact complex at different subcellular locations in live
cells. We therefore developed a first-generation mTORC1 activ-
ity reporter, TORCAR. When expressed in cells, TORCAR
responded to different stimuli, such as GF, total AA mixture,
leucine, and PMA, suggesting that TORCAR can be used as
a molecular tool to monitor endogenous mTORC1 activity.
TORCAR offers several unique advantages. TORCAR can be
genetically targeted to any specific subcellular location and is
not restricted by the localization of endogenous substrates,
thus allowing amore comprehensivemapping of mTORC1 activ-
ity. Genetic targeting also helps achieve high spatial resolution
and specific detection of mTORC1 activities in subcellular re-
gions, some of which may not be easily distinguished by stan-
dard microscopy (Mehta and Zhang, 2011), for example,
signaling domains such as membrane microdomains and multi-
protein complexes. In addition, TORCAR provides high temporal
resolution in detecting the activity. In the co-imaging experi-
ments, we showed that a PDGF-induced calcium spike immedi-
ately precedes the onset of TORC1 activity; this kind of temporal
information is difficult to obtain using conventional approaches
such as immunostaining. With a ratiometric readout of TORCAR,
variations in illumination and cell thickness, etc., can also be
cancelled out to provide more quantitative data, which allows
us to compare the activities stimulated by different signals.
Last but not least, TORCAR allows dynamic information to be
obtained from the contexts of living cells, which avoids potential
artifacts introduced by cell fixation. In summary, TORCAR com-
plements the current approaches based on phosphorylation-
specific antibodies and should be of great value to the field.
Future efforts will further enhance TORCAR for example by
improving its dynamic range, as shown in the case of other ki-
nase activity reporters (Depry et al., 2011; Gao and Zhang, 2008).
There is a long-standing interest in investigating the link be-
tween calcium signaling and mTORC1 activation (Altamirano
et al., 2009; Ghislat et al., 2012; Gulati et al., 2008; Mercan
et al., 2013). Many possible links have been suggested, yet the
exact role of calcium in mTORC1 activation remains to be
elucidated. Downstream of calcium, several potential mTORC1
regulators and mechanisms have been proposed, including
Ca2+/CaM, PI(3)P/hVps34, PA/PLD, PI(3,5)P2/PIKFYVE, and
PI3K-C2a. For example, it has been suggested in HeLa cells
that AAs induced an intracellular calcium increase, which acti-
vates calmodulin and in turn promotes its binding to hVps34, a
class III PI3K. The binding of Ca2+/CaM to hVps34 enhances(E) LeuOMe induced a TORCAR-NLS response (mean response ± SEM as
8.2% ± 1.8%, n = 7).
See also Movie S2.
s
the production of PI-3-phosphate, which is required formTORC1
activation (Gulati et al., 2008). It has also been indicated that cal-
ciummay regulate the activity of phospholipase D (PLD), thereby
providing positive inputs to mTOR (Fang et al., 2001; Razmara
et al., 2013). By co-imaging TORCAR with a calcium probe, we
demonstrated that in DS NIH 3T3 cells, PDGF induced a tran-
sient calcium spike that most likely originates from intracellular
calcium stores and partially contributes to the mTORC1 activity.
Upstream of mTORC1, Akt activity appeared to be largely
dependent on calcium as well. We show that intracellular cal-
cium chelation attenuated the phosphorylation of Akt S473,
but had no effect on the phosphorylation of Akt T308, which is
consistent with previous findings (Farrer et al., 2013; Razmara
et al., 2013). It has been shown that the S473 phosphorylation
is less critical for regulating Akt activity toward TSC2 (Jacinto
et al., 2006), which may explain the reduced effect of chelation
of intracellular calcium on mTORC1 activity (40% reduction)
compared with the effect on Akt activity (70% reduction).
TORCAR was successfully targeted to various subcellular
locations, including the lysosome, plasma membrane, and
nucleus, where it detected multiple pools of mTORC1 activity.
It appears that membrane compartments serve as specific
signaling platforms for mTORC1 activation, as the direct and
potent mTORC1 activator, Rheb, localizes to most endomem-
branes and anchors itself by farnesylation (Buerger et al., 2006;
Takahashi et al., 2005). In many such locations, TSC1/2 is also
present (Wienecke et al., 1995), implying that the Akt/TSC/
Rheb axis may exist and spatially regulate mTORC1 signaling.
Particularly at the lysosome, we detected Akt activity in response
to PDGF, and blockade of this Akt activity significantly dimin-
ished lysosomal mTORC1 activity. This suggests that Akt, which
either localized to the lysosomal surface or translocated there
upon PDGF stimulation, is an indispensable signal to fully acti-
vatemTORC1. Recently, Menon et al. (2014) reported that the in-
sulin-induced dissociation of the TSC complex from lysosomes
requires Akt-mediated TSC2 phosphorylation. Our finding pro-
vides evidence that increased lysosomal Akt activity is critical
for GF-induced lysosomal mTORC1 activity. It remains unclear
whether GF signaling recruits Akt to the lysosome or a pool of
lysosomal Akt is poised in situ to activate mTORC1.
We detected mTORC1 activity in the plasma membrane upon
GF stimulation. Although there are still conflicting data on the
presence of Rheb in the plasma membrane, a recent study sug-
gested that Ral GTPase may also regulate mTORC1 signaling at
the plasma membrane (Martin et al., 2014). This study showed
that serum-inducedmTOR recruitment to the plasmamembrane
is dependent on RalB GTPase and that suppression of the RalB
GTPase signaling at the plasma membrane reduced the serum-
induced mTOR translocation to plasma membrane and mTOR-
dependent phosphorylation of S6K. Although plasmamembrane
mTORC1 activity was not directly probed in this study, the
importance of a plasma membrane pool of RalB in regulating
mTOR membrane translocation and substrate phosphorylation
may suggest an alternative model of mTORC1 activation,
which could account for the mTORC1 activity in the plasma
membrane observed in our study. Further studies would
examine the mechanisms underlying the plasma membrane
mTORC1 activity, whether the TSC complex dissociates fromCellthe plasma membrane upon the phosphorylation of TSC2 by
Akt, as does lysosomal mTORC1 (Menon et al., 2014), and
whether the Ral GAP/Ral pathway contributes to the plasma
membrane mTORC1 activity.
This study also identified the nucleus as a new location where
both GF and AA stimulation can induce an increase in mTORC1
activity. Whether mTORC1 is functional and present in the nu-
clear compartment was a topic of debate. For instance, it has
been suggested that there is little intact mTORC1 in the nucleus
due to low affinity of nuclear raptor to mTOR than cytoplasmic
raptor (Rosner and Hengstschla¨ger, 2008). On the other hand,
nuclear mTORC1 signaling has been suggested to play a role
in some cellular processes, including promoting the transcription
of metabolic genes for ribosome biogenesis, lipid formation, and
mitochondrial function (Back and Kim, 2011; Workman et al.,
2014). For instance, it has been shown that mTOR binds to
TFIIIC, a transcription factor that binds to pol III promoters, lead-
ing to enhanced protein synthesis in response to nutrients and
GFs (Kantidakis et al., 2010). As we have shown, both GF and
AA stimulation can lead to the accumulation of mTORC1 activity
in the nucleus, highlighting the presence of functional mTORC1
in this location. However, the similar kinetics between nuclear
TORCAR and diffusible TORCAR does not allow us to distinguish
between the two models of nuclear mTORC1 activation—
mTORC1 could either be activated in the nucleus as an
independent pool, or it could be translocated to the nucleus after
activation in the cytosol or another location.
Notably, whereas GF widely stimulates mTORC1 activity
across different subcellular locations, including the plasma
membrane, lysosome, and nucleus, leucine ester-induced
mTORC1 activity is more restricted to the lysosome and nucleus.
This signal-specific pattern has important implications. First, it
suggests that Akt, which is also widely distributed throughout
the cell, may mediate the GF-sensitive pathway, whereas the
AA-sensing machinery, which has been characterized for the
lysosome but has not been explored at other locations, is
restricted to specific subcellular compartments. Furthermore, it
has been suggested that the intracellular nutrients contribute
to the basal activation ofmTORC1, but further activation requires
GF (Dibble and Manning, 2013; Hara et al., 1998). Our results
suggested that such basal activation may occur in a subset of
compartments, whereas GF-stimulated further activation in-
duces more global effects. Intriguingly, the lysosome and nu-
cleus appear to be the sites where the two pathways converge,
underscoring the importance of the mTORC1 signaling control
within these two compartments. Further delineation of the mo-
lecular mechanisms by which mTORC1 is regulated by specific
signals will advance our understanding of this signaling network
and facilitate the identification of potential targets for treating hu-
man diseases that involve aberrant mTORC1 signaling.
EXPERIMENTAL PROCEDURES
Detailed experimental procedures are provided in the Supplemental Experi-
mental Procedures.
Constructs
TORCAR was generated by sandwiching full-length 4EBP1 between a FRET
pair, Cerulean, and YPet. Details regarding subcellularly targeted TORCARReports 10, 1767–1777, March 17, 2015 ª2015 The Authors 1775
constructs are provided in the Supplemental Experimental Procedures. All
constructs were verified by sequencing after subcloning into a modified
version of the mammalian expression vector pcDNA3.
Live-Cell Imaging
Cells were washed once with modified Hank’s balance salt solution (HBSS)
and imaged in the dark at room temperature. Images were acquired on a Zeiss
Axiovert 200M microscope with a cooled charge-coupled device camera, as
previously described (Ananthanarayanan et al., 2005). Dual-emission ratio im-
aging was performed with a 420DF20 excitation filter, a 450DRLP dichroic
mirror, and two emission filters, 475DF40 and 535DF25 for CFP and YFP,
respectively. For RFP, a 568DF55 excitation filter, a 600DRLP dichroic mirror,
and a 653DF95 emission filter were used. Exposure times were 50–500 ms,
and images were taken every 30 s. Imaging data were analyzed with Metafluor
6.2 software (Universal Imaging). Fluorescence images were background
corrected by deducting the background (regions with no cells) from the
emission intensities of CFP or YFP. Regions of interest (ROIs) at the cell
periphery representing the plasma membrane were used for analysis for
PM-TORCAR. Traces were normalized by setting the emission ratio before
addition of drugs as 1.
Statistical Analysis
Data are shown as means ± SEM. Means were compared by two-tailed t test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and two movies and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2015.02.031.
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